CD8+Cell Noncytotoxic Antiviral Response in Long-Term HIV-1 Infected Former Blood Donors in China

被引:2
|
作者
Yuan, Lin [1 ]
Ma, Liying [1 ]
Fan, Xiujuan [1 ]
Feng, Yi [1 ]
Peng, Hong [1 ]
Zhao, Quanbi [1 ]
Ruan, Yuhua [1 ]
Levy, J. A. [2 ]
Shao, Yiming [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 100050, Peoples R China
[2] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
关键词
HIV; CNAR; CD4+cell count; former blood donor (FBD); long-term survivor; acute infection assay; ANTI-HIV RESPONSE; ANTIRETROVIRAL THERAPY; REPLICATION; STAGE;
D O I
10.2174/157016209788680561
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most of the HIV-infected long term survivors show strong CD8+ cell noncytotoxic antiviral response (CNAR) that plays as an important factor for maintaining the relative healthy state of infected individuals. HIV infected former blood donors (FBDs) in Anhui, China are the unique population that considered infected by the same or a related HIV strain by the same exposure route, and is better to be studied for viral and host immunological factors associated with disease progression, such as CNAR. We examined CNAR in 63 asymptomatic untreated HIV infected FBDs with different CD4+ cell counts and plasma viral loads. The average CD8+ : CD4+ cell ratio to reach 90% suppression of HIV replication in the groups with CD4+ cell counts of >500, 300-500 and <300 cells/mu l were 0.85 : 1, 1.47 : 1 and 1.88 : 1 respectively (P<0.0001). The average CD8+ : CD4+ cell ratio to reach 90% suppression of HIV replication was 1.07 : 1 and 1.66 : 1 in the group with plasma viral load of <30,000 and >30,000 RNA copy/ml respectively (P=0.0002). The results indicated that CNAR activity in long-term HIV-1 infected FBDs correlates directly with CD4+ cell counts, and correlates reversely with plasma viral loads. Our findings in long term infected FBDs confirm the clinical relevancy of CNAR and suggest that CNAR could be an additional marker to help determine the optimal time for starting therapy in HIV infected person.
引用
收藏
页码:437 / 440
页数:4
相关论文
共 50 条
  • [31] Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infection
    Grabar, S
    Le Moing, V
    Goujard, C
    Egger, M
    Leport, C
    Kazatchkine, MD
    Weiss, L
    Costagliola, D
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) : 284 - 292
  • [32] HIV-1 proviral DNA in purified peripheral blood CD34+stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy
    Tassaneetrithep, Boonrat
    Phuphuakrat, Angsana
    Pasomsub, Ekawat
    Bhukhai, Kanit
    Wongkummool, Wasinee
    Priengprom, Thongkoon
    Khamaikawin, Wannisa
    Chaisavaneeyakorn, Sujittra
    Anurathapan, Usanarat
    Apiwattanakul, Nopporn
    Hongeng, Suradej
    HELIYON, 2024, 10 (04)
  • [33] Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana
    Koofhethile, Catherine K.
    Moyo, Sikhulile
    Kotokwe, Kenanao P.
    Chang, Charlotte
    Mokgethi, Patrick
    Muchoba, Lorato
    Mokgweetsi, Selebogo
    Makhema, Joseph
    Lockman, Shahin
    Gaseitsiwe, Simani
    de Oliveira, Tulio
    Essex, M.
    Shapiro, Roger
    Kanki, Phyllis
    Novitsky, Vladimir
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (01) : 16 - 23
  • [34] The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs
    Botha, Johannes C.
    Demirov, Dimiter
    Gordijn, Carli
    Katusiime, Mary Grace
    Bale, Michael J.
    Wu, Xiaolin
    Wells, Daria
    Hughes, Stephen H.
    Cotton, Mark F.
    Mellors, John W.
    Kearney, Mary F.
    van Zyl, Gert U.
    MBIO, 2023, 14 (04): : e0111623
  • [35] Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy
    Ndumbi, P.
    Gillis, J.
    Raboud, J.
    Cooper, C.
    Hogg, R. S.
    Montaner, J. S. G.
    Burchell, A. N.
    Loutfy, M. R.
    Machouf, N.
    Klein, M. B.
    Tsoukas, C.
    HIV MEDICINE, 2014, 15 (03) : 153 - 164
  • [36] Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection
    Yang, Hongbing
    Wu, Hao
    Hancock, Gemma
    Clutton, Genevieve
    Sande, Nellia
    Xu, Xiaoning
    Yan, Huiping
    Huang, Xiaojie
    Angus, Brian
    Kuldanek, Kristin
    Fidler, Sarah
    Denny, Thomas N.
    Birks, Jacqueline
    McMichael, Andrew
    Dorrell, Lucy
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (04) : 552 - 561
  • [37] Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy
    Collazos, J.
    Valle-Garay, E.
    Carton, J. A.
    Montes, A. H.
    Suarez-Zarracina, T.
    De la Fuente, B.
    Asensi, V.
    HIV MEDICINE, 2016, 17 (07) : 532 - 541
  • [38] Persistent But Not Replicating HIV-1 Cell-Associated DNA in Semen of Long-Term ART Experienced Men
    Gagneux-Brunon, Amandine
    Nasri, Dorsaf
    Terrasse, Rachel
    Saune, Karine
    Gagnieu, Marie-Claude
    Fresard, Anne
    Delezay, Olivier
    Izopet, Jacques
    Pozzetto, Bruno
    Lucht, Frederic
    Bourlet, Thomas
    CURRENT HIV RESEARCH, 2016, 14 (04) : 316 - 323
  • [39] Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro
    Mujib, Shariq
    Saiyed, Aamir
    Fadel, Saleh
    Bozorgzad, Ardalan
    Aidarus, Nasra
    Yue, Feng Yun
    Benko, Erika
    Kovacs, Colin
    Emert-Sedlak, Lori A.
    Smithgall, Thomas E.
    Ostrowski, Mario A.
    JCI INSIGHT, 2017, 2 (17):
  • [40] Epitope-dependent effect of long-term cART on maintenance and recovery of HIV-1-specific CD8+ T cells
    Kuse, Nozomi
    Gatanaga, Hiroyuki
    Zhang, Yu
    Chikata, Takayuki
    Oka, Shinichi
    Takiguchi, Masafumi
    JOURNAL OF VIROLOGY, 2023,